PPAR and LXR activators regulate ABCA12 expression in human keratinocytes.

PPAR and LXR activators regulate ABCA12 expression in human keratinocytes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

PPAR and LXR activators regulate ABCA12 expression in human keratinocytes. Abstract Text:

Yan J Jiang,Biao Lu,Peggy Kim,Gyorgy Paragh,Gerd Schmitz,Peter M Elias,Kenneth R Feingold,Yan J Jiang,Biao Lu,Peggy Kim,Gyorgy Paragh,Gerd Schmitz,Peter M Elias,Kenneth R Feingold,

ATP-binding cassette (ABC) transporter, family 12 (ABCA12), a member of the ABC superfamily, facilitates the delivery of lipids to lamellar bodies (LB) in keratinocytes, which is critical for permeability barrier function. Recently, gene mutations of ABCA12 were found to underlie Harlequin ichthyosis and lamellar ichthyosis, two devastating skin disorders. Previously we and others have demonstrated that peroxisome proliferators-activated receptors (PPARs) and liver X receptor (LXR) activation improved epidermal permeability barrier homeostasis by stimulating keratinocyte differentiation, lipid synthesis, and increasing LB formation/secretion. Here we report that both PPAR-gamma and -beta/delta activators markedly stimulate ABCA12 mRNA expression in cultured human keratinocyte (CHK) in a dose- and time-dependent manner. Increased ABCA12 mRNA levels are accompanied by an increase in ABCA12 protein, suggesting biological importance of this upregulation. LXR activators also increase ABCA12 mRNA levels in CHK, but to a lesser extent. In contrast, activators of PPAR-alpha, RAR, RXR, or vitamin D receptor did not alter ABCA12 expression. Two major ABCA12 alternative transcripts and their corresponding proteins are also expressed and upregulated by PPAR or LXR activator in both undifferentiated and differentiated CHK. Together, our data demonstrate that PPAR and LXR activators increase ABCA12 expression, providing an additional mechanism by which PPAR and LXR activators promote epidermal permeability barrier homeostasis.

PPAR and LXR activators regulate ABCA12 expression in human keratinocytes. Publishing Authors By Initials

YJ Jiang,B Lu,P Kim,G Paragh,G Schmitz,PM Elias,KR Feingold,YJ Jiang,B Lu,P Kim,G Paragh,G Schmitz,PM Elias,KR Feingold,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

PPAR and LXR activators regulate ABCA12 expression in human keratinocytes. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: The Journal of investigative dermatology

VOLUME: 128

Page Numbers: 104-9

Journal Abbreviation: J. Invest. Dermatol.

ISSN: 1523-1747

DAY: 5

MONTH: 07

YEAR: 2007

PPAR and LXR activators regulate ABCA12 expression in human keratinocytes. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 426720

PPAR and LXR activators regulate ABCA12 expression in human keratinocytes. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: PPAR and LXR activators regulate ABCA12 expression in human keratinocytes. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for PPAR and LXR activators regulate ABCA12 expression in human keratinocytes.

AFFILIATION: Metabolism Section, Department of Veterans Affairs Medical Center, Northern California Institute for Research and Education, University of California at San Francisco, San Francisco, California 94121, USA. yan.jiang@med.va.gov

Country: United States

AGENCY: United States NIAMS

GRANT: AR39448

ACRONYM: AR

MEDLINETA: J Invest Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

PPAR and LXR activators regulate ABCA12 expression in human keratinocytes Related Publications

• A case of portal venous gas after extracorporeal shockwave lithotripsy and obstructive pyelonephritis.
• A hierarchical model for estimating significance levels of non-parametric linkage statistics for large pedigrees.
• Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2.
• Adverse drug interactions clinically important for the dermatologist.
• Antibiotic prophylaxis against bacterial endocarditis in patients undergoing dermatologic surgery.
• Bacterial adherence, colonization, and pathogenicity.
• Cell Shape Dynamics in Escherichia coli.
• Deficiency of PPARbeta/delta in the Epidermis Results in Defective Cutaneous Permeability Barrier Homeostasis and Increased Inflammation.
• Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications.
• Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response.
• Gene-dropping vs. empirical variance estimation for allele-sharing linkage statistics.
• Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function.
• In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. potential role of hepatocyte nuclear factor-1.
• Medical and vocational cooperation for the aging.
• PPAR and LXR activators regulate ABCA12 expression in human keratinocytes.
• Patterns of expressed emotion and patient coping styles that characterise the families of recent onset schizophrenics.
• Principles of human genetics in relation to insurance medicine and public health.
• Random thoughts continued.
• Regulation of ABCA1 expression in human keratinocytes and murine epidermis.
• Robust Score Statistics for QTL Linkage Analysis.
• Segregation analysis of the Jacobsen data.
• Staphylococcal scalded skin syndrome in an adult.
• Subtyping familial schizophrenia: reliability, concordance, and stability.
• The importance of lipids in cutaneous function.
• The influence of acute infection upon the course of allergy in children; some clinical observations.
• Thematic Review Series: Skin Lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology.
• Thematic review series: Skin Lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis.
• Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.
• Tumor necrosis factor, cytokines, and the hyperlipidemia of infection.
• Web-Based Identification of Evolutionary Conserved DNA cis-Regulatory Elements.